Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Vantris

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Background ACE inhibitors (iACE) antifibrotic mechanisms for CKD progression is still investigated among them their influence for… Expand
2016
2016
PURPOSE Despite the benefits of the minimally invasive endoscopic treatment for vesicoureteral reflux (VUR) it has a major… Expand
  • table 1
2014
2014
PurposeWe aimed to evaluate prospectively the efficacy of Vantris as a new non-biodegradable tissue-augmenting substance in… Expand
  • table 1
  • table 2
2014
2014
OBJECTIVE Our aim was to evaluate the efficacy and safety of single endoscopic injection of Vantris in young girls affected by… Expand
  • table 1
  • table 2
  • table 3
  • table 4
2013
2013
OBJECTIVE To evaluate the efficacy of Vantris in children with vesicoureteral reflux (VUR) after 3 years of prospective follow-up… Expand
  • table 1
  • table 2
2013
2013
Background: To investigate the effect of polyacrylate polyalcohol copolymer (Vantris) injection for the correction of VUR in… Expand
  • table 1
  • table 2
  • table 3
2013
2013
Background: Role of pelvic osteotomy in surgical management of bladder exstrophy is controversial But pelvic rim closure… Expand
  • table 1
  • figure 2
2013
2013
From June 1991 to December 2011, endoscopic treatment of vesicoureteral reflux (VUR) was performed more than in 4,000 children… Expand
2011
2011
PURPOSE The aim of this study was to evaluate the efficacy of single injection of a new non-biodegradable agent (Vantris… Expand
  • table 1
  • table 2
2008
2008
Biodegradable injectable bulking agents of animal origin present a fast rate of bio-reabsorption and may cause an allergic… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table I